DRVd Treatment

DVRd is a powerful, frontline treatment regimen designed to achieve a deep and lasting remission. This video breaks down this four-drug combination therapy, explaining how each component works to attack myeloma cells from different angles. Our goal is to demystify this standard-of-care treatment so you can feel prepared and informed.

In this video, we cover:

• The Power of Four: An introduction to combination therapy and why using four drugs together is so effective against multiple myeloma.

• Meet the Components: A clear explanation of each drug in the regimen:

  • Daratumumab: An immunotherapy that targets a protein called CD38 on myeloma cells.

  • Revlimid® (lenalidomide): An oral drug that activates your immune system and stops cancer cells from growing.

  • Velcade® (bortezomib): A therapy that disrupts how cancer cells manage proteins, causing them to die.

  • dexamethasone: A steroid used to support the treatment and fight myeloma cells.

• Your Treatment Schedule: A look at what to expect, including the cycles of infusions, injections, and oral medications.

• Managing Common Side Effects: A practical discussion of potential side effects, such as fatigue and neuropathy, and how your care team will help manage them.